跳至主要内容
临床试验/JPRN-jRCT2080220543
JPRN-jRCT2080220543未知3 期

A Long Term Study to Investigate the Efficacy and Safety Study of D961H (20 mg Once Daily) for the Prevention of Gastric and/or Duodenal Ulcers Associated With Daily Nonsteroidal Anti-Inflammatory Drug (NSAID) Use

AstraZeneca0 个研究点开始时间: 2008年4月9日最近更新:

试验速览

阶段
3 期
发起方
AstraZeneca

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Ages Eligible for Study: 20 Years and older
  • Genders Eligible for Study: Both
  • Accepts Healthy Volunteers: No
  • Inclusion Criteria:
  • -Medical history of gastric and/or duodenal ulcer
  • -A diagnosis of a chronic condition (rheumatoid arthritis, osteoarthritis, lumbago,etc) that requires daily NSAID use,at least 20 years of age

排除标准

  • -Having gastric or duodenal ulcer in active or healing stage according to the Sakita/Miwa classification
  • -History of esophageal, gastric or duodenal surgery
  • -Having severe liver disease or chronic renal disease

研究者

发起方
AstraZeneca

相似试验